Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07332143 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Psilocybin-Assisted Therapy

StatusRecruiting
PhasePhase 2
Started2026-06-08
View on ClinicalTrials.gov ↗

Amendment history

2026-10-02
notable
Recruitment opened
2026-05-21
minor
Study Status, Contacts/Locations v2
Start date2026-05→2026-06
Study sitescontacts updated at 1 of 1 site
2026-04-22
minor
Study Identification, Study Status v1
Start date2026-03→2026-05
Study title-11 characters
Psilocybin-Assisted Randomized Therapy
2026-01-08
minor
Original filing
812 trials monitored
See 45 trials at risk
This pilot study will examine the safety, tolerability, acceptability, and efficacy of combination psilocybin + psychotherapy to decrease PTSD symptoms. Participants will be randomized into two different treatment groups, allowing the investigators to directly compare PE augmented with psilocybin and psilocybin-assisted psychotherapy.
Trial Details
NCT Number NCT07332143
Lead Sponsor Emory University
Collaborators: Georgia Department of Veterans Services
Conditions PTSD
Enrollment 150 participants
Start Date 2026-06-08
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-10-01